Accenture Impairment and restructuring decreased by 100.0% to $0.00 in Q4 2025 compared to the prior quarter. Over 2 years (FY 2023 to FY 2025), Impairment and restructuring shows a downward trend with a -23.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High levels indicate significant operational disruption or strategic realignment, often impacting short-term profitability.
The aggregate expense recognized for asset write-downs and costs associated with restructuring operations, such as facil...
Frequently used by capital-intensive firms to isolate non-recurring costs from core operating performance.
msft_impairment_and_restructuring| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $265.79M | $265.79M | $265.79M | $265.79M | $109.61M | $109.61M | $109.61M | $109.61M | $0.00 | $0.00 | $0.00 | $615.32M | $307.54M | $0.00 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -58.8% | +0.0% | +0.0% | +0.0% | -100.0% | — | — | — | -50.0% | -100.0% |
| YoY Change | — | — | — | — | -58.8% | -58.8% | -58.8% | -58.8% | -100.0% | -100.0% | -100.0% | +461.4% | — | — |